Open AccessA randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children
Author(s) -
Paediatric European Network for Treatment of AIDS
Publication year - 1998
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199814000-00002
Subject(s) - lamivudine , didanosine , placebo , zidovudine , medicine , interquartile range , zalcitabine , adverse effect , tolerability , reverse transcriptase inhibitor , randomization , emtricitabine , viral load , stavudine , gastroenterology , clinical trial , virology , viral disease , human immunodeficiency virus (hiv) , antiretroviral therapy , virus , pathology , hepatitis b virus , alternative medicine